Natural course and treatment of pancreatic exocrine insufficiency in a nationwide cohort of chronic pancreatitis

High Impact Factor (IF > 5) — 4 citations

1. NDE Thierens, RC Verdonk, JM Löhr…. Chronic pancreatitis. The Lancet. 2024.

   IF 88.5PDF
2. N Kattner, A Bashir, JAM Shaw. The emerging role of pancreatic exocrine fibrosis as a common aetiological driver of islet dysfunction and diabetes: opportunities for novel disease-modifying …. Diabetologia. 2026. doi:10.1007/s00125-026-06678-6.

   IF 10.2PDF
3. JE Dominguez‐Muñoz, M Vujasinovic…. European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based …. United European …. 2025. doi:10.1002/ueg2.12674 PMID:39639485.

   IF 6.7PDF
4. M Murruste, Ü Kirsimägi, K Kase…. Complications of chronic pancreatitis prior to and following surgical treatment: A proposal for classification. World journal of …. 2022. doi:10.12998/wjcc.v10.i22.7808 PMID:36158501.

   IF 5.8PDF